Lawrence W. Argenbright

746 total citations
14 papers, 628 citations indexed

About

Lawrence W. Argenbright is a scholar working on Immunology and Allergy, Hematology and Dermatology. According to data from OpenAlex, Lawrence W. Argenbright has authored 14 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology and Allergy, 5 papers in Hematology and 3 papers in Dermatology. Recurrent topics in Lawrence W. Argenbright's work include Cell Adhesion Molecules Research (5 papers), Platelet Disorders and Treatments (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Lawrence W. Argenbright is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Platelet Disorders and Treatments (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Lawrence W. Argenbright collaborates with scholars based in United States. Lawrence W. Argenbright's co-authors include R W Barton, Robert Rothlein, L. Gordon Letts, Iwao Kurose, D. Neil Granger, R. Wolf, P. Donald Forbes, Gwendolyn J. Stewart, Robert J. Bonney and Laura O’Grady and has published in prestigious journals such as Nature, Journal of Clinical Investigation and British Journal of Pharmacology.

In The Last Decade

Lawrence W. Argenbright

13 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence W. Argenbright United States 11 224 195 123 79 74 14 628
Gianluca Micheletti Italy 8 178 0.8× 92 0.5× 293 2.4× 43 0.5× 75 1.0× 8 808
Gianna Mannori Italy 7 218 1.0× 362 1.9× 420 3.4× 81 1.0× 42 0.6× 11 817
Richard A. McReynolds United States 11 142 0.6× 148 0.8× 130 1.1× 34 0.4× 45 0.6× 14 854
Jeanny Ohan France 6 416 1.9× 91 0.5× 414 3.4× 179 2.3× 73 1.0× 10 1.0k
Ethan S. Weiner United States 12 141 0.6× 112 0.6× 126 1.0× 20 0.3× 125 1.7× 16 1.1k
Giuseppe Dell’Elba Italy 11 160 0.7× 94 0.5× 102 0.8× 150 1.9× 65 0.9× 18 483
Maria Świątkowska Poland 17 143 0.6× 121 0.6× 313 2.5× 139 1.8× 89 1.2× 38 841
Lia Guidotti Italy 16 189 0.8× 51 0.3× 378 3.1× 240 3.0× 108 1.5× 27 964
Teruaki Kimura Japan 16 375 1.7× 132 0.7× 321 2.6× 54 0.7× 56 0.8× 27 974
Michael Silverberg United States 14 289 1.3× 28 0.1× 245 2.0× 200 2.5× 69 0.9× 33 991

Countries citing papers authored by Lawrence W. Argenbright

Since Specialization
Citations

This map shows the geographic impact of Lawrence W. Argenbright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence W. Argenbright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence W. Argenbright more than expected).

Fields of papers citing papers by Lawrence W. Argenbright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence W. Argenbright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence W. Argenbright. The network helps show where Lawrence W. Argenbright may publish in the future.

Co-authorship network of co-authors of Lawrence W. Argenbright

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence W. Argenbright. A scholar is included among the top collaborators of Lawrence W. Argenbright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence W. Argenbright. Lawrence W. Argenbright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kurose, Iwao, et al.. (1997). Ischemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators. American Journal of Physiology-Heart and Circulatory Physiology. 272(6). H2976–H2982. 94 indexed citations
2.
Kurose, Iwao, Lawrence W. Argenbright, D C Anderson, et al.. (1997). Reperfusion-induced leukocyte adhesion and vascular protein leakage in normal and hypercholesterolemic rats. American Journal of Physiology-Heart and Circulatory Physiology. 273(2). H854–H860. 32 indexed citations
3.
Kurose, Iwao, Lawrence W. Argenbright, Robert Wolf, & D. Neil Granger. (1996). Oxidative Stress During Platelet‐Activating Factor‐Induced Microvascular Dysfunction. Microcirculation. 3(4). 401–410. 22 indexed citations
4.
Norman, Keith E., Lawrence W. Argenbright, Timothy J. Williams, & Adriano G. Rossi. (1994). Role of adhesion glycoproteins CD 18 and intercellular adhesion molecule‐1 in complement‐mediated reactions of rabbit skin. British Journal of Pharmacology. 111(1). 117–122. 9 indexed citations
5.
Argenbright, Lawrence W. & R W Barton. (1992). Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited.. Journal of Clinical Investigation. 89(1). 259–272. 138 indexed citations
6.
Argenbright, Lawrence W., L. Gordon Letts, & Robert Rothlein. (1991). Monoclonal Antibodies to the Leukocyte Membrane CD18 Glycoprotein Complex and to Intercellular Adhesion Molecule-1 Inhibit Leukocyte-Endothelial Adhesion in Rabbits. Journal of Leukocyte Biology. 49(3). 253–257. 129 indexed citations
7.
Argenbright, Lawrence W. & R W Barton. (1991). The Shwartzman response: A model of ICAM-1 dependent vasculitis. Inflammation Research. 34(1-2). 208–210. 15 indexed citations
8.
Opas, Evan E., Lawrence W. Argenbright, & John L. Humes. (1989). An enzymatic method for distinguishing the stereoisomers of 12-hydroxyeicosatetraenoic acid in human epidermis and psoriatic scale. British Journal of Dermatology. 120(1). 49–58. 11 indexed citations
9.
Bonney, Robert J., et al.. (1987). Assessment of gastric bleeding in rats: Effects of cyclooxygenase inhibitors and 16,16-dimethyl prostaglandin E2 on gastric bleeding. Inflammation Research. 21(3-4). 310–313. 4 indexed citations
10.
Doherty, James B., Bonnie M. Ashe, Lawrence W. Argenbright, et al.. (1986). Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase. Nature. 322(6075). 192–194. 134 indexed citations
11.
Argenbright, Lawrence W. & P. Donald Forbes. (1982). Erythema and skin blood content. British Journal of Dermatology. 106(5). 569–574. 12 indexed citations
12.
Argenbright, Lawrence W., P. Donald Forbes, & Gwendolyn J. Stewart. (1980). Quantitation of Phototoxic Hyperemia and Permeability to Protein: II. Inihibition by Histamine (H1 and H2) Receptor Antagonists in Mouse Skin. Journal of Investigative Dermatology. 75(5). 417–420. 14 indexed citations
13.
Argenbright, Lawrence W., P. Donald Forbes, & Gwendolyn J. Stewart. (1980). Quantitation of phototoxic hyperemia and permeability to protein. Experimental and Molecular Pathology. 32(2). 154–161. 14 indexed citations
14.
Argenbright, Lawrence W. & P. Donald Forbes. (1979). Micro vascular response during photo sensitized uva induced inflammation in pig skin effect of histamine and serotonin antagonists. Journal of Investigative Dermatology. 72(4). 203.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026